ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TLX Telix Pharmaceuticals Limited

14.81
-0.605 (-3.92%)
May 17 2024 - Closed
Delayed by 20 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20172017201820192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 54.53M51.09M76.71M102.61M157.82M109.81M255.35M398.3M
Total Current Assets 53.45M49.55M35.86M58.68M93.63M47.54M173.23M224.85M
Cash and Equivalents 52.42M48.76M25.77M44.6M77.95M22.04M116.33M123.24M
Total Non-Current Assets 53.72M49.29M52.9M70.08M79.02M2.16M80.01M148.91M
Total Liabilities 816k1.8M23.81M32.53M78.81M107.66M175.35M249.39M
Total Current Liabilities 816k1.47M8.24M10.63M19.96M37.98M85.56M157.41M
Total Non-Current Liabilities 0333k16.16M22.19M58.94M69.67M93.1M100.19M
Total Equity 53.72M49.29M52.9M70.08M79.02M2.16M80.01M148.91M
Common Equity 55.29M55.56M72.05M115.94M167.06M170.84M370.97M446.27M
Retained Earnings -1.57M-6.38M-20.21M-48.07M-92.96M-173.47M-272.82M-263.67M

Your Recent History

Delayed Upgrade Clock